Please assess the completion status of the following clinical trial:

Trial Title: Dose Ranging Study of Metronidazole Vaginal Gel in the Treatment of Bacterial Vaginosis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE2
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Females at least 18 years of age~* In good general health~* Confirmed current diagnosis of bacterial vaginosis (determined at study screening)~* Negative pregnancy test (for women who are able to become pregnant)~* Must abstain from sexual intercourse throughout the first 7 days of thes study~* Must abstain from alcohol ingestion during the treatment period and for one day afterward~* Must not use intra-vaginal products for the duration of the study~Exclusion Criteria:~* Pregnant, lactating, or planning to become pregnant during the study period~* Menstruating at the time of the diagnosis or anticipate the onset of menses during the treatment phase of the study~* Had a medical event within 90 days of the visit (e.g., stroke, heart attack, etc.)~* Received specific treatments/medications /therapy within the designated time period prior to study enrollment

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1D (Type: ACTIVE_COMPARATOR): None
- 3D (Type: ACTIVE_COMPARATOR): None
- 5D (Type: ACTIVE_COMPARATOR): None
- Metronidazole (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).